Expectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industry.

scientific article published on 28 February 2015

Expectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industry. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00210-015-1106-5
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/s00210-015-1106-5
P698PubMed publication ID25720948

P50authorMartin Christian MichelQ57055217
P2093author name stringMarjan Amiri
P2860cites workCommon misconceptions about data analysis and statisticsQ24289509
Using publication metrics to highlight academic productivity and research impactQ28597772
Public-private partnership: a new engine for translational research in neurosciencesQ34450523
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.Q34487762
Relationships between authors of clinical practice guidelines and the pharmaceutical industryQ34520801
The FDA critical path initiative and its influence on new drug development.Q34734622
A new bibliometric index based on the shape of the citation distributionQ34776417
Playing well with others! Initiating and sustaining successful collaborations between industry, academia and governmentQ35111663
Public-private partnerships as driving forces in the quest for innovative medicinesQ36588385
Drug discovery: new models for industry-academic partnershipsQ37320886
The future is much closer collaboration between the pharmaceutical industry and academic medical centersQ37734858
The use and misuse of statistical methodologies in pharmacology researchQ38112962
Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxationQ39253820
How significant are your data? The need for a culture shiftQ44686659
Bench to beside: motivation for university industry partnershipQ48242708
Grants4Targets: an open innovation initiative to foster drug discovery collaborations.Q51032202
Financial conflict of interest in medical research: overview and analysis of federal and state controlsQ73306966
Editorial: The Innovative Medicines Initiative--collaborations are key to innovating R&D processesQ85221892
Academia and big pharma UnitedQ87022252
P433issue6
P921main subjectcollaborationQ1145523
P304page(s)613-622
P577publication date2015-02-28
P1433published inNaunyn-Schmiedeberg's Archives of PharmacologyQ1468251
P1476titleExpectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industry.
P478volume388

Reverse relations

cites work (P2860)
Q28076506Opportunities and Challenges for Drug Development: Public-Private Partnerships, Adaptive Designs and Big Data
Q38411081Preclinical research strategies for newly approved drugs as reflected in early publication patterns

Search more.